The incidence of BMs associated with EGFR mutant NSCLC considerably surpasses the incidence of BMs in NSCLC with driver aberrations, such as Anaplastic Lymphoma Kinase (ALK) rearrangements or in wt disease [128,129,130]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.